133 related articles for article (PubMed ID: 15182733)
1. Inhibition of glycolipid biosynthesis by N-(5-adamantane-1-yl-methoxy-pentyl)-deoxynojirimycin protects against the inflammatory response in hapten-induced colitis.
Shen C; Bullens D; Kasran A; Maerten P; Boon L; Aerts JM; Van Assche G; Geboes K; Rutgeerts P; Ceuppens JL
Int Immunopharmacol; 2004 Jul; 4(7):939-51. PubMed ID: 15182733
[TBL] [Abstract][Full Text] [Related]
2. Treatment of genetically obese mice with the iminosugar N-(5-adamantane-1-yl-methoxy-pentyl)-deoxynojirimycin reduces body weight by decreasing food intake and increasing fat oxidation.
Langeveld M; van den Berg SA; Bijl N; Bijland S; van Roomen CP; Houben-Weerts JH; Ottenhoff R; Houten SM; van Dijk KW; Romijn JA; Groen AK; Aerts JM; Voshol PJ
Metabolism; 2012 Jan; 61(1):99-107. PubMed ID: 21816446
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of glycosphingolipid synthesis induces a profound reduction of plasma cholesterol and inhibits atherosclerosis development in APOE*3 Leiden and low-density lipoprotein receptor-/- mice.
Bietrix F; Lombardo E; van Roomen CP; Ottenhoff R; Vos M; Rensen PC; Verhoeven AJ; Aerts JM; Groen AK
Arterioscler Thromb Vasc Biol; 2010 May; 30(5):931-7. PubMed ID: 20167657
[TBL] [Abstract][Full Text] [Related]
4. Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance.
Elson CO; Beagley KW; Sharmanov AT; Fujihashi K; Kiyono H; Tennyson GS; Cong Y; Black CA; Ridwan BW; McGhee JR
J Immunol; 1996 Sep; 157(5):2174-85. PubMed ID: 8757344
[TBL] [Abstract][Full Text] [Related]
5. A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice.
Sun X; Somada S; Shibata K; Muta H; Yamada H; Yoshihara H; Honda K; Nakamura K; Takayanagi R; Tani K; Podack ER; Yoshikai Y
Gastroenterology; 2008 Feb; 134(2):447-58. PubMed ID: 18242212
[TBL] [Abstract][Full Text] [Related]
6. The glucosylceramide synthase inhibitor N-(5-adamantane-1-yl-methoxy-pentyl)-deoxynojirimycin induces sterol regulatory element-binding protein-regulated gene expression and cholesterol synthesis in HepG2 cells.
Bijl N; Scheij S; Houten S; Boot RG; Groen AK; Aerts JM
J Pharmacol Exp Ther; 2008 Sep; 326(3):849-55. PubMed ID: 18550691
[TBL] [Abstract][Full Text] [Related]
7. Sinomenine attenuates 2, 4, 6-trinitrobenzene sulfonic acid-induced colitis in mice.
Cheng H; Xia B; Guo Q; Zhang L; Wang F; Jiang L; Wang Z; Zhang Y; Li C
Int Immunopharmacol; 2007 May; 7(5):604-11. PubMed ID: 17386408
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppressive activity of a new pteridine derivative (4AZA1378) alleviates severity of TNBS-induced colitis in mice.
Shen C; Dillissen E; Kasran A; Lin Y; Herman J; Sienaert I; De Jonghe S; Kerremans L; Geboes K; Boon L; Rutgeerts P; Ceuppens JL
Clin Immunol; 2007 Jan; 122(1):53-61. PubMed ID: 17070110
[TBL] [Abstract][Full Text] [Related]
9. PARP inhibition reduces acute colonic inflammation in rats.
Sánchez-Fidalgo S; Villegas I; Martín A; Sánchez-Hidalgo M; Alarcón de la Lastra C
Eur J Pharmacol; 2007 Jun; 563(1-3):216-23. PubMed ID: 17374531
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory activity of a pteridine derivative (4AZA2096) alleviates TNBS-induced colitis in mice.
Shen C; Dillissen E; Kasran A; Lin Y; Clydesdale G; Sienaert I; Jonghe SD; Gao LJ; Geboes K; Boon L; Rutgeerts P; Ceuppens JL
J Interferon Cytokine Res; 2006 Aug; 26(8):575-82. PubMed ID: 16881868
[TBL] [Abstract][Full Text] [Related]
11. Minocycline attenuates experimental colitis in mice by blocking expression of inducible nitric oxide synthase and matrix metalloproteinases.
Huang TY; Chu HC; Lin YL; Lin CK; Hsieh TY; Chang WK; Chao YC; Liao CL
Toxicol Appl Pharmacol; 2009 May; 237(1):69-82. PubMed ID: 19285099
[TBL] [Abstract][Full Text] [Related]
12. Redirection of regulatory T cells with predetermined specificity for the treatment of experimental colitis in mice.
Elinav E; Waks T; Eshhar Z
Gastroenterology; 2008 Jun; 134(7):2014-24. PubMed ID: 18424268
[TBL] [Abstract][Full Text] [Related]
13. Modulation of glycosphingolipid metabolism significantly improves hepatic insulin sensitivity and reverses hepatic steatosis in mice.
Bijl N; Sokolović M; Vrins C; Langeveld M; Moerland PD; Ottenhoff R; van Roomen CP; Claessen N; Boot RG; Aten J; Groen AK; Aerts JM; van Eijk M
Hepatology; 2009 Nov; 50(5):1431-41. PubMed ID: 19731235
[TBL] [Abstract][Full Text] [Related]
14. Enteral diets enriched with medium-chain triglycerides and N-3 fatty acids prevent chemically induced experimental colitis in rats.
Kono H; Fujii H; Ogiku M; Tsuchiya M; Ishii K; Hara M
Transl Res; 2010 Nov; 156(5):282-91. PubMed ID: 20970751
[TBL] [Abstract][Full Text] [Related]
15. Si-Ni-San, a traditional Chinese prescription, and its active ingredient glycyrrhizin ameliorate experimental colitis through regulating cytokine balance.
Sun Y; Cai TT; Shen Y; Zhou XB; Chen T; Xu Q
Int Immunopharmacol; 2009 Nov; 9(12):1437-43. PubMed ID: 19733696
[TBL] [Abstract][Full Text] [Related]
16. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice.
Zhao J; de Vera J; Narushima S; Beck EX; Palencia S; Shinkawa P; Kim KA; Liu Y; Levy MD; Berg DJ; Abo A; Funk WD
Gastroenterology; 2007 Apr; 132(4):1331-43. PubMed ID: 17408649
[TBL] [Abstract][Full Text] [Related]
17. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile.
Daniel C; Sartory NA; Zahn N; Radeke HH; Stein JM
J Pharmacol Exp Ther; 2008 Jan; 324(1):23-33. PubMed ID: 17911375
[TBL] [Abstract][Full Text] [Related]
18. The water-soluble extract from cultured medium of Ganoderma lucidum (Reishi) mycelia (Designated as MAK) ameliorates murine colitis induced by trinitrobenzene sulphonic acid.
Hanaoka R; Ueno Y; Tanaka S; Nagai K; Onitake T; Yoshioka K; Chayama K
Scand J Immunol; 2011 Nov; 74(5):454-62. PubMed ID: 21973321
[TBL] [Abstract][Full Text] [Related]
19. Amelioration of immune-mediated experimental colitis: tolerance induction in the presence of preexisting immunity and surrogate antigen bystander effect.
Gotsman I; Shlomai A; Alper R; Rabbani E; Engelhardt D; Ilan Y
J Pharmacol Exp Ther; 2001 Jun; 297(3):926-32. PubMed ID: 11356912
[TBL] [Abstract][Full Text] [Related]
20. Paeonol attenuates TNBS-induced colitis by inhibiting NF-kappaB and STAT1 transactivation.
Ishiguro K; Ando T; Maeda O; Hasegawa M; Kadomatsu K; Ohmiya N; Niwa Y; Xavier R; Goto H
Toxicol Appl Pharmacol; 2006 Nov; 217(1):35-42. PubMed ID: 16928387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
